Granulocyte colony-stimulating factor; HLA: Human leukocyte antigens; HMGB1: High mobility group protein B1; ICAM 1: Intercellular adhesion molecule 1; ICU: Intensive care unit; IFN-?: Interferongamma ; IL: Interleukin; IP-10: Interferon gamma-induced protein 10 ,
15 Service de maladies infectieuses et tropicales, p.38043 ,
Centre hospitalier de Versailles, 177, rue de Versailles, 78150 Le Chesnay, France. 17 Intensive Care -SIRS Unit, University Hospitals of Geneva, 4 rue Gabrielle Perret-Gentil, Geneva, vol.16, issue.14, pp.75014-75034, 1211. ,
Biomarkers and surrogate endpoints: preferred definitions and conceptual framework, Clin Pharmacol Ther, vol.69, pp.89-95, 2001. ,
Considerations in the Evaluation of Surrogate Endpoints in Clinical Trials, Controlled Clinical Trials, vol.22, issue.5, pp.485-502, 2001. ,
DOI : 10.1016/S0197-2456(01)00153-2
Apport des Marqueurs Biologiques de l'Infection aux Urgences et en Réanimation, Réanimation Médicale, pp.988-992, 2009. ,
Biomarker discovery and development in pediatric critical care medicine*, Pediatric Critical Care Medicine, vol.12, issue.2, pp.165-173, 2011. ,
DOI : 10.1097/PCC.0b013e3181e28876
Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infections?hope for hype, Swiss Med Wkly, vol.139, pp.318-326, 2009. ,
Performance evaluation of human cytokines profiles obtained by various multiplexed-based technologies underlines a need for standardization, Clinical Chemistry and Laboratory Medicine, vol.51, issue.7, pp.1-9 ,
DOI : 10.1515/cclm-2012-0648
Sepsis: definition, epidemiology, and diagnosis, BMJ, vol.335, issue.7625, pp.879-883, 2007. ,
DOI : 10.1136/bmj.39346.495880.AE
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2043413
Sepsis biomarkers: a review, Critical Care, vol.14, issue.1, p.15, 2010. ,
DOI : 10.1186/cc8872
Biomarkers for pediatric sepsis and septic shock, Expert Review of Anti-infective Therapy, vol.9, issue.1, pp.71-79, 2011. ,
DOI : 10.1586/eri.10.154
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033193
C-Reactive Protein Is a Useful Marker for Guiding Duration of Antibiotic Therapy in Suspected Neonatal Bacterial Infection, PEDIATRICS, vol.99, issue.2, pp.216-221, 1997. ,
DOI : 10.1542/peds.99.2.216
Use of C-reactive protein to guide duration of empiric antibiotic therapy in suspected early neonatal sepsis, The Pediatric Infectious Disease Journal, vol.19, issue.6, pp.531-535, 2000. ,
DOI : 10.1097/00006454-200006000-00008
Role of C-reactive protein in deciding duration of antibiotic therapy in neonatal septicemia, Indian Pediatr, vol.40, pp.880-883, 2003. ,
Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia, American Journal of Respiratory and Critical Care Medicine, vol.174, issue.1, pp.84-93, 2006. ,
DOI : 10.1164/rccm.200512-1922OC
Procalcitonin-Guided Antibiotic Use vs a Standard Approach for Acute Respiratory Tract Infections in Primary Care, Archives of Internal Medicine, vol.168, issue.18, pp.2000-2007, 2007. ,
DOI : 10.1001/archinte.168.18.2000
Effect of Procalcitonin-Based Guidelines vs Standard Guidelines on Antibiotic Use in Lower Respiratory Tract Infections, JAMA, vol.302, issue.10, pp.1059-1066, 2009. ,
DOI : 10.1001/jama.2009.1297
Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection, European Respiratory Journal, vol.36, issue.3, pp.601-607, 2010. ,
DOI : 10.1183/09031936.00163309
Procalcitonin to Guide Initiation and Duration of Antibiotic Treatment in Acute Respiratory Infections: An Individual Patient Data Meta-Analysis, Clinical Infectious Diseases, vol.55, issue.5, pp.651-662, 2012. ,
DOI : 10.1093/cid/cis464
Use of Procalcitonin to Shorten Antibiotic Treatment Duration in Septic Patients, American Journal of Respiratory and Critical Care Medicine, vol.177, issue.5, pp.498-505, 2008. ,
DOI : 10.1164/rccm.200708-1238OC
Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial, Critical Care, vol.13, issue.3, p.83, 2009. ,
DOI : 10.1186/cc7903
Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study, European Respiratory Journal, vol.34, issue.6, pp.1364-1375, 2009. ,
DOI : 10.1183/09031936.00053209
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial, The Lancet, vol.375, issue.9713, pp.463-474, 2010. ,
DOI : 10.1016/S0140-6736(09)61879-1
Use of Procalcitonin-Guided Decision-Making to Shorten Antibiotic Therapy in Suspected Neonatal Early-Onset Sepsis: Prospective Randomized Intervention Trial, Neonatology, vol.97, issue.2, pp.165-174, 2010. ,
DOI : 10.1159/000241296
Soluble Form of the Triggering Receptor Expressed on Myeloid Cells-1 as a Marker of Microbial Infection, Clinical Medicine & Research, vol.2, issue.3, pp.181-187, 2004. ,
DOI : 10.3121/cmr.2.3.181
Soluble Triggering Receptor Expressed on Myeloid Cells and the Diagnosis of Pneumonia, New England Journal of Medicine, vol.350, issue.5, pp.451-458, 2004. ,
DOI : 10.1056/NEJMoa031544
Soluble triggering receptor expressed on myeloid cells-1 for distinguishing bacterial from aseptic meningitis in adults, European Journal of Clinical Microbiology & Infectious Diseases, vol.74, issue.9, pp.647-650, 2007. ,
DOI : 10.1007/s10096-007-0343-z
Soluble triggering receptor expressed on myeloid cells 1: a??biomarker for bacterial meningitis, Intensive Care Medicine, vol.141, issue.8, pp.1243-1247, 2006. ,
DOI : 10.1007/s00134-006-0240-4
Diagnostic Accuracy of HMGB-1, sTREM-1, and CD64 as Markers of Sepsis in Patients Recently Admitted to the Emergency Department, Academic Emergency Medicine, vol.83, issue.Suppl 2, pp.807-815, 2011. ,
DOI : 10.1111/j.1553-2712.2011.01113.x
Prognostic value of inflammatory markers (notably cytokines and procalcitonin), nutritional assessment, and organ function in patients with sepsis, Eur Cytokine Netw, vol.21, pp.19-26, 2010. ,
Measurement of Plasma STREM-1 in Patients With Severe Sepsis Receiving Early Goal-Directed Therapy and Evaluation of Its Usefulness, Shock, vol.37, issue.6, pp.574-578, 2012. ,
DOI : 10.1097/SHK.0b013e318250da40
Plasma levels of soluble urokinase-type plasminogen activator receptor (suPAR) and early mortality risk among patients enrolling for antiretroviral treatment in South Africa, BMC Infectious Diseases, vol.12, issue.1, p.41, 2007. ,
DOI : 10.1097/00002030-199813000-00011
Elevated levels of soluble urokinase receptor in serum from mycobacteria infected patients: Still looking for a marker of treatment efficacy, Scandinavian Journal of Infectious Diseases, vol.24, issue.11-12, pp.1028-1032, 2006. ,
DOI : 10.1038/nm0396-287
Serum levels of soluble urokinase plasminogen activator receptor is associated with parasitemia in children with acute Plasmodium falciparum malaria infection, Parasite Immunology, vol.99, issue.5, pp.207-211, 2004. ,
DOI : 10.1093/jnci/91.10.869
Why high suPAR is not super - diagnostic, prognostic and potential pathogenic properties of a novel biomarker in the ICU, Critical Care, vol.15, issue.6, p.1020, 2011. ,
DOI : 10.1038/nm.2411
Clinical value of suPAR, a new biomarker, Intensive Care Med, vol.37, p.199, 2011. ,
Plasma level of soluble urokinase-type plasminogen activator receptor as a predictor of disease severity and case fatality in patients with bacteraemia: a prospective cohort study, Journal of Internal Medicine, vol.345, issue.1, pp.32-40, 2011. ,
DOI : 10.1111/j.1365-2796.2011.02363.x
A Prediction Rule to Identify Low-Risk Patients with Community-Acquired Pneumonia, New England Journal of Medicine, vol.336, issue.4, pp.243-250, 1997. ,
DOI : 10.1056/NEJM199701233360402
Risk prediction with procalcitonin and clinical rules in communityacquired pneumonia, Ann Emerg Med, issue.48, pp.5258-5300, 2008. ,
Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia, Swiss Med Wkly, vol.142, p.13542, 2012. ,
Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397], Critical Care, vol.10, issue.3, p.96, 2006. ,
DOI : 10.1210/en.2004-1424
Midregional Proadrenomedullin as a Prognostic Tool in Community-Acquired Pneumonia, Chest, vol.136, issue.3, pp.823-831, 2009. ,
DOI : 10.1378/chest.08-1981
Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis, Journal of Infection and Chemotherapy, vol.11, issue.5, pp.234-238, 2005. ,
DOI : 10.1007/s10156-005-0400-4
Soluble CD14 subtype presepsin (sCD14-ST) and lipopolysaccharide binding protein (LBP) in neonatal sepsis: new clinical and analytical perspectives for two old biomarkers, The Journal of Maternal-Fetal & Neonatal Medicine, vol.180, issue.3, pp.2412-2426, 2011. ,
DOI : 10.1002/(SICI)1521-4141(199901)29:01<265::AID-IMMU265>3.0.CO;2-G
Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome, Journal of Infection and Chemotherapy, vol.17, issue.6, pp.764-769, 2011. ,
DOI : 10.1007/s10156-011-0254-x
Infection and Its Negative Regulatory Role in the Inflammatory Response, The Journal of Infectious Diseases, vol.200, issue.6, pp.916-925, 2009. ,
DOI : 10.1086/605443
miR-155: an ancient regulator of the immune system, Immunological Reviews, vol.22, issue.1, pp.146-157, 2013. ,
DOI : 10.1111/imr.12057
MicroRNA Fingerprints Identify miR-150 as a Plasma Prognostic Marker in Patients with Sepsis, PLoS ONE, vol.5, issue.6, p.7405, 2009. ,
DOI : 10.1371/journal.pone.0007405.s002
Serum MicroRNA Signatures Identified by Solexa Sequencing Predict Sepsis Patients??? Mortality: A Prospective Observational Study, PLoS ONE, vol.127, issue.6, p.38885, 2012. ,
DOI : 10.1371/journal.pone.0038885.s005
Role of biomarkers in the management of antibiotic therapy: an expert panel review: I ??? currently available biomarkers for clinical use in acute infections, Annals of Intensive Care, vol.3, issue.1, p.22, 2013. ,
DOI : 10.1371/journal.pone.0038885
URL : https://hal.archives-ouvertes.fr/hal-01004760